声音 同日，PLCO试验的主要研究者安德里奥尔（Andriole）在接受Medscape网站采访时说： 这两项研究的试验设计、样本人群和进行活检的PSA水平分界点并不相同，故无法比较二者结论。
基于1个网页-相关网页
By the end of the study, after about 16 months, Andriole says the symptom scores improved for both groups of men.
到研究结束时，大约16个月后，安德利·奥勒说男子两组症状评分的改善。
"If the PSA level starts rising while a man is on this drug, that is a very strong signal that he has an aggressive tumor" and needs a biopsy, Andriole said.
“如果服用该药的男性PS A值开始上升，这是一个很强的患上侵润肿瘤的信号”且需要进行活检，Andriole说。
That means that men "are less likely to be diagnosed with cancer that is not likely to kill them, so they are less likely to undergo aggressive treatment," Andriole said.
这意味着男性“可以减少患那些不容易致命的前列腺癌的风险，因此他们可以少接受侵入性治疗，”Andriole说。
应用推荐